10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2019 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2019 10-K (Filed: Feb 19, 2020) | ||
(In Thousands, except shares in actual) | ||
As of | As of | |
Dec 31, 2019 | Dec 31, 2018 | |
Assets | ||
Current Assets | ||
Cash and cash equivalents (Note 7) | $ 7,998,200 | |
Cash and cash equivalents (Note 7) | 2,337,500 | 7,320,700 |
Short-term investments (Note 7) | 101,000 | 88,200 |
Accounts receivable, net of allowances of $22.4 (2019) and $24.1 (2018) | 4,547,300 | 4,593,900 |
Other receivables | 994,200 | 1,182,900 |
Inventories (Note 6) | 3,190,700 | 3,098,100 |
Prepaid expenses and other | 2,538,900 | 2,036,700 |
Current assets of discontinued operations (Note 19) | 0 | 2,229,100 |
Total current assets | 13,709,600 | 20,549,600 |
Investments (Note 7) | 1,962,400 | 2,005,400 |
Goodwill (Note 8) | 3,679,400 | 1,366,600 |
Other intangibles, net (Note 8) | 6,618,000 | 1,068,000 |
Deferred tax assets (Note 14) | 2,572,600 | 2,613,700 |
Property and equipment, net (Note 9) | 7,872,900 | 7,996,100 |
Operating lease assets (Note 10) | 532,100 | 530,000 |
Other noncurrent assets | 2,339,100 | 1,824,900 |
Noncurrent assets of discontinued operations (Note 19) | 0 | 6,484,100 |
Total assets | 39,286,100 | 43,908,400 |
Liabilities and Equity | ||
Current Liabilities | ||
Short-term borrowings and current maturities of long-term debt (Note 11) | 1,499,300 | 1,102,200 |
Accounts payable | 1,405,300 | 1,207,100 |
Employee compensation | 915,500 | 955,600 |
Sales rebates and discounts | 4,933,600 | 4,849,500 |
Dividends payable | 671,500 | 650,800 |
Income taxes payable (Note 14) | 160,600 | 393,400 |
Other current liabilities | 2,189,400 | 2,036,700 |
Current liabilities of discontinued operations (Note 19) | 0 | 692,800 |
Total current liabilities | 11,775,200 | 11,888,100 |
Other Liabilities | ||
Long-term debt (Note 11) | 13,817,900 | 9,196,400 |
Noncurrent operating lease liabilities (Note 10) | 486,700 | |
Accrued retirement benefits (Note 15) | 3,698,200 | 2,802,200 |
Long-term income taxes payable (Note 14) | 3,607,200 | 3,700,000 |
Other noncurrent liabilities | 1,014,300 | 1,357,600 |
Deferred tax liabilities (Note 14) | 2,187,500 | 1,312,700 |
Noncurrent liabilities of discontinued operations (Note 19) | 0 | 2,742,300 |
Total other liabilities | 24,811,800 | 21,111,200 |
Commitments and Contingencies (Note 16) | ||
Eli Lilly and Company Shareholders' Equity (Notes 12 and 13) | ||
Common stockno par value Authorized shares: 3,200,000 Issued shares: 958,056 (2019) and 1,057,639 (2018) | 598,800 | 661,000 |
Additional paid-in capital | 6,685,300 | 6,583,600 |
Retained earnings | 4,920,400 | 11,395,900 |
Employee benefit trust | (3,013,200) | (3,013,200) |
Accumulated other comprehensive loss (Note 17) | (6,523,600) | (5,729,200) |
Cost of common stock in treasury | (60,800) | (69,400) |
Total Eli Lilly and Company shareholders' equity | 2,606,900 | 9,828,700 |
Noncontrolling interests | 92,200 | 1,080,400 |
Total equity | 2,699,100 | 10,909,100 |
Total liabilities and equity | 39,286,100 | 43,908,400 |
External Links | |
ELI LILLY & CO (LLY) Fiscal Year 2019 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |